- Sorafenib - a new molecule for the treatment of differentiated thyroid cancer2015 | Publication without faculty affiliation
- Sorafenib2007 | First Faculty of Medicine
- Sorafenib in the treatment of generalized malignant melanoma: An overview of clinical trials +12009 | Publication without faculty affiliation
- Place of sorafenib in the treatment of hepatocellular carcinoma2010 | First Faculty of Medicine
- Research Report University Hospital for clinical evaluation of BAY 73-4506/15982Publication without faculty affiliation
- New options for biologically targeted therapy of advanced non-small-cell lung cancer - sunitinib and sorasfenib2010 | Central Library of Charles University
- New possibilities of systemic treatment of thyroid cancer2018 | Publication without faculty affiliation
- Comments on the study SHARP2009 | First Faculty of Medicine
- Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma-data from the Czech registry2012 | First Faculty of Medicine
- Skin toxicity and efficacy of sunitinib and sorafenib in metastatic renal cell carcinoma: a national registry-based study2012 | First Faculty of Medicine
- Clinical and laboratory prognostic factors in patients with metastatic renal cell carcinoma treated with sunitinib and sorafenib after progression on cytokines2014 | First Faculty of Medicine, Second Faculty of Medicine
- Advances in the treatment of advanced hepatocellular carcinoma2012 | First Faculty of Medicine
- Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma2012 | First Faculty of Medicine
- Porovnání výsledků léčby HCC sorafenibem ve studii SHARP a v klinické praxi2019 | First Faculty of Medicine
- Renal cell carcinoma 20152015 | First Faculty of Medicine
- A Pooled Analysis of Sequential Therapies with Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma2012 | First Faculty of Medicine
- New perspectives of the systemic treatment for renal cancer2008 | First Faculty of Medicine
- NEXAVAQR clinical registry2010 | First Faculty of Medicine
- New possibility of the hepatocellular carcinoma therapy (HCC) +12009 | Faculty of Medicine in Hradec Králové
- New possibility of the hepatocellular carcinoma therapy (HCC)2009 | First Faculty of Medicine
- Biological treatment of hepatocellular carcinoma2010 | First Faculty of Medicine
- Systemic treatment of renal cell carcinoma and news in 20142014 | First Faculty of Medicine
- Prognostic factors in renal cell carcinoma patients treated with sorafenib: results from the Czech registry2015 | First Faculty of Medicine
- New possibilities of targeted therapy of thyroid cancer2017 | Publication without faculty affiliation
- Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells2020 | Faculty of Medicine in Hradec Králové
- The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line.2010 | Faculty of Medicine in Pilsen
- Sorafenib Treatment of Advanced Renal Cell Carcinoma Patients in Daily Practice: The Large International PREDICT Study2015 | First Faculty of Medicine
- Sunitib in adjuvant treatment for renal cell carcinoma2017 | Publication without faculty affiliation